伊人不卡,国产乱码一二三区精品,亚洲午夜综合,亚洲网站在线,亚洲国产二区三区,开心伊人网,tiantianri

Global EditionASIA 中文雙語(yǔ)Fran?ais
China
Home / China / Latest

Beijing expands COVID-19 testing

By DU JUAN | chinadaily.com.cn | Updated: 2022-04-26 00:12
Share
Share - WeChat
A medical worker takes a swab sample from a woman for a nucleic acid test at a testing site in Chaoyang district of Beijing on April 25, 2022. [Photo by Wei Xiaohao/chinadaily.com.cn]

Beijing will conduct three rounds of nucleic acid testing for novel coronavirus starting on Tuesday for all residents in 11 districts including Dongcheng, Xicheng, Haidian, Fengtai in addition to Chaoyang, which started testing on Monday.

"Based on the current epidemic situation, the authority decided to expand the nucleic acid testing to more areas," said Xu Hejian, spokesperson of Beijing municipal government, at a news conference on Monday night.

Three rounds of tests will be completed between Tuesday and Saturday.

During this period, Beijing will suspend all the cultural and art events, sports games, exhibitions and large-scale commercial promotions, as well as the training courses after school.

All interior decoration works should also be suspended until the tests are completed.

"The authority has the confidence and capability to fight against the COVID-19 epidemic," he said.

Chaoyang district, where more than half of Beijing's recent cases were reported, had completed tests for 3.69 million residents by 8pm on Monday and 526,457 have come out negative by far, according to Yang Beibei, deputy head of Chaoyang district.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US